12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).
1 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC
50 = 40 μM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction
in vitro.
1